loadpatents
name:-0.042176008224487
name:-0.012204885482788
name:-0.0073919296264648
Olmstead; Kay Patent Filings

Olmstead; Kay

Patent Applications and Registrations

Patent applications and USPTO patent grants for Olmstead; Kay.The latest application filed is for "pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them".

Company Profile
6.13.29
  • Olmstead; Kay - San Diego CA
  • OLMSTEAD; Kay - Escondido CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pharmaceutical Formulations Useful For Inhibiting Acid Secretion And Methods For Making And Using Them
App 20220133778 - Olmstead; Kay ;   et al.
2022-05-05
Pkc Inhibitor Solid State Forms
App 20220048918 - OLMSTEAD; Kay ;   et al.
2022-02-17
Pharmaceutical Composition For Preventing Or Treating Obesity, Containing CYCLO(HIS-PRO) As Active Ingredient
App 20210401880 - Lee; Heon Jong ;   et al.
2021-12-30
Formulations of 5-fluorocytosine and uses thereof
Grant 11,191,764 - Gruber , et al. December 7, 2
2021-12-07
Therapeutic Agent Nanoparticles And Methods Of Preparation
App 20210290543 - Olmstead; Kay ;   et al.
2021-09-23
PKC inhibitor solid state forms
Grant 11,104,679 - Olmstead , et al. August 31, 2
2021-08-31
Pharmacological Formulation Comprising Cyclo (HIS-PRO) As Effective Ingredient For Preventing Or Treating Diabetes Mellitus
App 20210100872 - Lee; Heon Jong ;   et al.
2021-04-08
Novel Polymorphic Forms Of Cyclo (-his-pro)
App 20210061854 - OLMSTEAD; Kay ;   et al.
2021-03-04
Formulations Of 5-fluorocytosine And Uses Thereof
App 20200281929 - Gruber; Harry E. ;   et al.
2020-09-10
Pkc Inhibitor Solid State Forms
App 20200223850 - OLMSTEAD; Kay ;   et al.
2020-07-16
Polymorphic forms of Cyclo (-His-Pro)
Grant 10,683,300 - Olmstead , et al.
2020-06-16
Novel Polymorphic Forms Of Cyclo (-his-pro)
App 20200017509 - Olmstead; Kay ;   et al.
2020-01-16
Formulations of 5-fluorocytosine and uses thereof
Grant 10,449,194 - Gruber , et al. Oc
2019-10-22
Pharmaceutical Formulations Useful For Inhibiting Acid Secretion And Methods For Making And Using Them
App 20190022131 - Olmstead; Kay ;   et al.
2019-01-24
Formulations Of 5-fluorocytosine And Uses Thereof
App 20190015414 - Gruber; Harry E. ;   et al.
2019-01-17
Formulations of 5-fluorocytosine and uses thereof
Grant 9,889,133 - Gruber , et al. February 13, 2
2018-02-13
Formulations Of 5-fluorocytosine And Uses Thereof
App 20160235751 - Gruber; Harry E. ;   et al.
2016-08-18
Formulations of 5-fluorocytosine and uses thereof
Grant 9,320,738 - Gruber , et al. April 26, 2
2016-04-26
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
App 20150202226 - Hall; Warren ;   et al.
2015-07-23
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
Grant 8,993,599 - Hall , et al. March 31, 2
2015-03-31
Pharmaceutical Formulations Useful for Inhibiting Acid Secretion and Methods for Making and Using Them
App 20150044303 - Olmstead; Kay ;   et al.
2015-02-12
Pharmaceutical Formulation And Method For Treating Acid Caused Gastrointestinal Disorders
App 20140370104 - HALL; Warren ;   et al.
2014-12-18
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
Grant 8,906,940 - Olmstead , et al. December 9, 2
2014-12-09
Novel Formulations Of Proton Pump Inhibitors And Methods Of Using These Formulations
App 20140271853 - Hall; Warren ;   et al.
2014-09-18
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
Grant 8,815,916 - Olmstead , et al. August 26, 2
2014-08-26
Formulations Of 5-fluorocytosine And Uses Thereof
App 20110268720 - Gruber; Harry E. ;   et al.
2011-11-03
Pharmaceutical Formulation And Method For Treating Acid-Caused Gastrointestinal Disorders
App 20100297220 - Hall; Warren ;   et al.
2010-11-25
Novel Formulations Of Proton Pump Inhibitors And Methods Of Using These Formulations
App 20090092658 - Hall; Warren ;   et al.
2009-04-09
Sustained Release Methotrexate Formulations And Methods Of Use Thereof
App 20080268045 - Dervieux; Thierry ;   et al.
2008-10-30
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
App 20060204585 - Hall; Warren ;   et al.
2006-09-14
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
App 20060147522 - Olmstead; Kay ;   et al.
2006-07-06
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
App 20050266071 - Olmstead, Kay ;   et al.
2005-12-01
Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory drug
App 20050249806 - Proehl, Gerald T. ;   et al.
2005-11-10
Combination of proton pump inhibitor and sleep aid
App 20050244517 - Hall, Warren ;   et al.
2005-11-03
Combination of proton pump inhibitor, buffering agent, and prokinetic agent
App 20050239845 - Proehl, Gerald T. ;   et al.
2005-10-27
Pharmaceutical formulatins useful for inhibiting acid secretion and methods for making and using them
App 20050037070 - Hall, Warren ;   et al.
2005-02-17
Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
App 20050031700 - Hall, Warren ;   et al.
2005-02-10
Transmucosal delivery of proton pump inhibitors
App 20040006111 - Widder, Kenneth ;   et al.
2004-01-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed